Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Dr. Mukul  Jain Ph.D.

Chief Operating Officer

Mr. Frederick T. Sullivan

Chief Financial Officer, Secretary & Treasurer

Dr. Francine Ratner Kaufman M.D.

Chief Medical Officer & Director

Dr. Timothy T. Goodnow Ph.D.

President, Chief Executive Officer & Director

Mr. Kenneth L. Horton

General Counsel & Corporate Development Advisor

Nom de l'entreprise	Capitalisation boursière
Edwards Lifesciences Corporation	0M
SofWave Medical Ltd.	0M
Eiken Chemical Co., Ltd.	0M
Nanjing Vishee Medical Technology Co., Ltd	0M
QHSLab, Inc.	0M
Vitrolife AB (publ)	0M
ReWalk Robotics Ltd.	0M
Bone Biologics Corporation	0M
Sinocare Inc.	0M
Hyperfine, Inc.	0M
Viemed Healthcare, Inc.	0M

Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Liste des concurrents

Principaux concurrents